Healthcare Services

Global Hypertrophic And Keloid Scar Treatment Market Expected to Reach $13.76 Billion by 2030 with 10.2% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Hypertrophic And Keloid Scar Treatment Market At The End Of The 2026–2030 Forecast Period?

The hypertrophic and keloid scar treatment market size has experienced significant expansion in recent years. This market is projected to expand from $8.49 billion in 2025 to $9.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. Historically, this growth can be ascribed to a rising volume of surgical procedures, an increase in trauma and burn cases, the extensive application of corticosteroid injections, the expansion of dermatology and cosmetic clinics, and the pronounced aesthetic effects of scars.

The hypertrophic and keloid scar treatment market size is expected to experience substantial expansion over the coming years. It is projected to reach $13.77 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.2%. This growth in the forecast period is primarily driven by a rising preference for non-invasive scar treatments, the increasing adoption of laser and radiotherapy techniques, growing awareness regarding early scar management, the expansion of combination treatment protocols, and improved access to advanced dermatology services. Prominent trends anticipated in this period include the increasing uptake of combination scar management therapies, a rising demand for minimally invasive and non-surgical treatments, the growing use of laser and energy-based scar revision techniques, the expansion of post-surgical and preventive scar care solutions, and a heightened focus on early intervention and long-term scar control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp

What Drivers Are Shaping The Future Growth Of The Hypertrophic And Keloid Scar Treatment Market?

The increasing prevalence of road accidents and burn injuries is projected to stimulate the expansion of the hypertrophic and keloid scar treatment market moving forward. Road accidents are defined as incidents occurring on a road involving at least one vehicle and individuals. Both road accidents and burn cases demand attention and appropriate measures for prevention and effective medical care. Hypertrophic and keloid scar treatments are utilized for individuals injured in road accidents to reduce the height and tightness of scars. A rise in road accidents and burn cases contributes to the growth of the hypertrophic and keloid scar treatment market. For instance, in January 2025, The Health Foundation, a UK-based independent organization, indicated that in 2023, 43 serious or fatal casualties occurred per billion miles traveled by car, in contrast to 1,032 for cyclists and 1,914 for motorcyclists, while 92 pedestrians per million residents were killed or seriously injured. Hence, the escalation in road accidents and burn cases will drive the hypertrophic and keloid scar treatment market.

What Segment Types Make Up The Hypertrophic And Keloid Scar Treatment Market?

The hypertrophic and keloid scar treatment market covered in this report is segmented –

1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments

2) By Products: Topical Products, Laser Products, Injectables, Other Products

3) By Scar: Hypertrophic Scars, Keloid Scars

4) By End-Use: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy

2) By Surgical Excision: Simple Excision, Excision With Skin Grafting

3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings

4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids

5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments

6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil

7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy

How Are Trends Transforming The Hypertrophic And Keloid Scar Treatment Market Landscape?

Leading companies in the hypertrophic and keloid scar treatment market are prioritizing the creation of clinically validated silicone-based products, such as medical-grade silicone strips, to boost their market earnings. Medical-grade silicone strips are therapeutic items crafted from superior silicone material, specifically formulated to encourage scar recovery and reduction. For instance, in April 2023, Scar Erase, a UK firm offering silicone-based scar reduction therapy, introduced Scar Erase silicone strips, a clinically proven and budget-friendly option for scar healing. Fashioned from 3mm of medical-grade silicone, these strips support the management of various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology surrounds the scar area, facilitating hydration and an optimal healing setting, which leads to substantial improvements in scar texture, color, and height. It is engineered for both comfort and subtlety, providing an easily accessible at-home treatment for scars.

Who Are The Key Players Driving Competition In The Hypertrophic And Keloid Scar Treatment Market?

Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen

Read the full hypertrophic and keloid scar treatment market report here:

https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Which Geographic Regions Are Influencing Demand In The Hypertrophic And Keloid Scar Treatment Market?

North America was the largest region in the hypertrophic and keloid scar treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hypertrophic And Keloid Scar Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10692&type=smp

Browse Through More Reports Similar to the Global Hypertrophic And Keloid Scar Treatment Market 2026, By The Business Research Company

Scar Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/scar-treatment-global-market-report

Keloids Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Neurotrophic Keratitis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795